The market has been leaning away from Hengan International Group, with the stock down over the past week and quarter even after the latest earnings release. Yet the core story today is less about short term price moves and more about what investors are paying for those earnings. Hengan is trading on a trailing P/E of 8.9x while the wider Asian personal products peer group sits much higher, and a discounted cash flow model suggests a fair value well above the current HK$22.7 share price. That valuation gap is now the central question for long term holders.

Is Hengan International Group really trading at a discount that the market will eventually close, or is the low P/E simply fair for its growth and dividend profile? See how the cash flow assumptions, peer multiples and market expectations line up in our valuation analysis for Hengan International Group

H1 2026 Earnings Summary

• Total Revenue H1 2026 TTM: CNY 23,068.869m vs. CNY 22,641.554m in H1 2025 TTM (reported one year revenue growth referenced at 10.3%)
• Net Income from Continuing Operations H1 2026 TTM: CNY 2,533.167m vs. CNY 2,262.099m in H1 2025 TTM (reported one year earnings growth of 10.3%)
• Basic EPS H1 2026 TTM: CNY 2.227306 per share vs. CNY 1.986651 per share in H1 2025 TTM (higher earnings per share over the period)
• Net Profit Margin H1 2026 TTM: 11% vs. 10.1% in the prior year (margin level higher year on year)

Prefer clear charts instead of another wall of earnings tables and P/E ratios? See Hengan International Group's full valuation picture in a clean visual dashboard through our company report for Hengan International Group.

Hengan earnings still support a defensive tilt

For investors who see Hengan International Group as a defensive consumer essentials business, the latest figures mostly point in the right direction. Trailing twelve month revenue and net income are both higher than a year ago, and net margin has moved from 10.1% to 11%. That suggests the model can still convert sales into profit even while the company reports a profit fall for the first half of 2026. The focus on brand power and product upgrades also fits a steady, cash generative profile rather than a high risk growth story.

Profit squeeze keeps the caution case alive

The bear case around competition and margin pressure still has real backing. Hengan International Group reported profit for the first half of 2026 that fell 8.7% year on year to CNY 1.25b, which aligns with concerns about pricing pressure in tissue and hygiene products. Management is prioritising brand strength and scale instead of aggressive market share gains, which can be read as a response to intense competition rather than clear pricing power. Recent share price weakness over 7, 30 and 90 days also hints that investors remain cautious on these risks.

Compare how Hengan International Group's higher trailing margins and recent profit squeeze stack up against institutional expectations, and see whether analysts think SEHK:1044 deserves a higher multiple or a deeper discount. See the consensus price target analysis for Hengan International Group

Stay Ahead With Simply Wall St

If the valuation gap and recent profit squeeze around Hengan International Group have your attention, register for free with Simply Wall St and add the stock to a Watchlist to monitor the share price against fair value and watch for a better entry point. After you own shares, use the Portfolio Command Center to filter out short term price noise and focus on key fundamental updates that matter for your holdings. For longer term conviction, turn to the Community to see what other investors are watching and how they view the same data. By surfacing potential catalysts and risks early, Simply Wall St aims to help you act with confidence and stay a step ahead of the market.

Seeking Alternatives Beyond Hengan International Group

Fresh stock ideas can move from quiet potential to full breakout before most investors react. Use that window while it matters and before momentum is fully caught. Act now.

• Spot resilient opportunities that keep risk scores in check by starting with 287 resilient stocks with low risk scores before the crowd chases the same calm corner of the market.
• Ride early AI momentum instead of watching it fly past by scanning the curated list of 76 profitable AI stocks that aren't just burning cash while margins and cash flows still look disciplined.
• Catch potential yield workhorses before income hunters bid them up by reviewing the hand picked set of 433 dividend fortresses while payouts remain under the radar for now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.